Cargando…
Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant
PURPOSE: To evaluate the efficacy of using a CRISPR/Cas-mediated strategy to correct a common high-risk allele that is associated with age-related macular degeneration (AMD; rs1061170; NM_000186.3:c.1204T>C; NP_000177.2:p.His402Tyr) in the complement factor H (CFH) gene. METHODS: A human embryoni...
Autores principales: | Tran, Minh Thuan Nguyen, Khalid, Mohd Khairul Nizam Mohd, Pébay, Alice, Cook, Anthony L., Liang, Helena H., Wong, Raymond C.B., Craig, Jamie E., Liu, Guei-Sheung, Hung, Sandy S., Hewitt, Alex W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441356/ https://www.ncbi.nlm.nih.gov/pubmed/30996586 |
Ejemplares similares
-
Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing
por: Nguyen Tran, Minh Thuan, et al.
Publicado: (2020) -
Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis
por: Chen, Guohai, et al.
Publicado: (2015) -
Comparison of CRISPR/Cas Endonucleases for in vivo Retinal Gene Editing
por: Li, Fan, et al.
Publicado: (2020) -
Interaction of Human Complement Factor H Variants Tyr(402) and His(402) with Leptospira spp.
por: Silva, Aldacilene Souza, et al.
Publicado: (2011) -
CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD
por: Magnusson, Kristinn P, et al.
Publicado: (2006)